FDA Inspection 1237110 — Bill T. Laitinen, M.D.
The FDA completed an inspection of Bill T. Laitinen, M.D. on Apr 18, 2024 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 18, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Boise, ID (United States)
Additional Details
Clinical Investigator (CI)